Sanchez-Fueyo A - Search Results

1

Understanding, predicting and achieving liver transplant tolerance: from bench to bedside.

Thomson AW, Vionnet J, Sanchez-Fueyo A. Thomson AW, et al. Nat Rev Gastroenterol Hepatol. 2020 Dec;17(12):719-739. doi: 10.1038/s41575-020-0334-4. Epub 2020 Aug 5. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32759983 Review.

2

Th1 to Th2 immune deviation facilitates, but does not cause, islet allograft tolerance in mice.

Zhang D, Sanchez-Fueyo A, Kawamoto K, Alexopoulos SP, Zhang W, Zheng XX. Zhang D, et al. Cytokine. 2010 Sep;51(3):311-9. doi: 10.1016/j.cyto.2010.06.007. Epub 2010 Jul 2. Cytokine. 2010. PMID: 20598563

3

Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs.

Sánchez-Fueyo A, Strom TB. Sánchez-Fueyo A, et al. Gastroenterology. 2011 Jan;140(1):51-64. doi: 10.1053/j.gastro.2010.10.059. Epub 2010 Nov 9. Gastroenterology. 2011. PMID: 21073873 Free PMC article. Review.

4

Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance.

Banff Working Group on Liver Allograft Pathology. Banff Working Group on Liver Allograft Pathology. Liver Transpl. 2012 Oct;18(10):1154-70. doi: 10.1002/lt.23481. Liver Transpl. 2012. PMID: 22645090 Free article. Review.

5

Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients.

Benítez C, Londoño MC, Miquel R, Manzia TM, Abraldes JG, Lozano JJ, Martínez-Llordella M, López M, Angelico R, Bohne F, Sese P, Daoud F, Larcier P, Roelen DL, Claas F, Whitehouse G, Lerut J, Pirenne J, Rimola A, Tisone G, Sánchez-Fueyo A. Benítez C, et al. Hepatology. 2013 Nov;58(5):1824-35. doi: 10.1002/hep.26426. Epub 2013 Sep 19. Hepatology. 2013. PMID: 23532679 Clinical Trial.

6

Immunosuppression minimization vs. complete drug withdrawal in liver transplantation.

Londoño MC, Rimola A, O'Grady J, Sanchez-Fueyo A. Londoño MC, et al. J Hepatol. 2013 Oct;59(4):872-9. doi: 10.1016/j.jhep.2013.04.003. Epub 2013 Apr 8. J Hepatol. 2013. PMID: 23578883 Free article. Review.

7

Tolerance profiles and immunosuppression.

Sanchez-Fueyo A. Sanchez-Fueyo A. Liver Transpl. 2013 Nov;19 Suppl 2:S44-8. doi: 10.1002/lt.23749. Liver Transpl. 2013. PMID: 24108496 Free article. No abstract available.

8

End-stage renal disease: Dual transplantation--the immunological role of the liver.

Martinez-Llordella M, Sanchez-Fueyo A. Martinez-Llordella M, et al. Nat Rev Nephrol. 2014 Jul;10(7):364-5. doi: 10.1038/nrneph.2014.78. Epub 2014 May 13. Nat Rev Nephrol. 2014. PMID: 24821651 No abstract available.

9

HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans.

Bohne F, Londoño MC, Benítez C, Miquel R, Martínez-Llordella M, Russo C, Ortiz C, Bonaccorsi-Riani E, Brander C, Bauer T, Protzer U, Jaeckel E, Taubert R, Forns X, Navasa M, Berenguer M, Rimola A, Lozano JJ, Sánchez-Fueyo A. Bohne F, et al. Sci Transl Med. 2014 Jun 25;6(242):242ra81. doi: 10.1126/scitranslmed.3008793. Sci Transl Med. 2014. PMID: 24964989 Clinical Trial.

10

Immunosuppression withdrawal following liver transplantation.

Whitehouse GP, Sanchez-Fueyo A. Whitehouse GP, et al. Clin Res Hepatol Gastroenterol. 2014 Dec;38(6):676-80. doi: 10.1016/j.clinre.2014.06.011. Epub 2014 Oct 1. Clin Res Hepatol Gastroenterol. 2014. PMID: 25281267 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page